- Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
-
Lee HJ, Moon Y, Choi J, Heo JD, Kim S, Nallapaneni HK, Chin YW, Lee J, Han SY
- KMID: 2531001
- Biomol Ther.
- 2022 Jul;30(4):360-367.
- doi: 10.4062/biomolther.2021.195
Tropomyosin receptor kinase A (TrkA) protein is a receptor tyrosine kinase encoded by the NTRK1 gene. TrkA signaling mediates the proliferation, differentiation, and survival of neurons and other cells following... -
- CITED
-
- Close
- SHARE
-
- Close
